Listed pharmas focusing on reducing SG&A expenses for high profitability

In order to raise profitability, listed pharmaceutical companies are focusing on reducing SG&A(selling, general & administrative) expenses.

It was criticized, however, the top pharmaceutical companies have been weakened in profitability because of the increased expenses for R&D.

According to the Yakup Shinmoon’s(www.yakup.com) analysis result of KOSPI and KOSDAQ listed pharmaceutical companie...